Yusuke Okuma, S. Nomura, Jun Sakakibara-Konishi, Y. Tsukita, Shuji Murakami, Y. Hosomi, Yuichi Tambo, Yoshihito Kogure, H. Yoshioka, M. Tamiya, Kiichiro Ninomiya, Eiji Iwama
{"title":"artemis:一项多中心、开放标签、单臂、II期研究,评估卡铂/紫杉醇/Lenvatinib/Pembrolizumab联合疗法一线治疗既往未治疗的晚期或复发性胸腺癌的疗效和安全性","authors":"Yusuke Okuma, S. Nomura, Jun Sakakibara-Konishi, Y. Tsukita, Shuji Murakami, Y. Hosomi, Yuichi Tambo, Yoshihito Kogure, H. Yoshioka, M. Tamiya, Kiichiro Ninomiya, Eiji Iwama","doi":"10.1016/j.cllc.2024.02.002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":504941,"journal":{"name":"Clinical Lung Cancer","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of first-line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas\",\"authors\":\"Yusuke Okuma, S. Nomura, Jun Sakakibara-Konishi, Y. Tsukita, Shuji Murakami, Y. Hosomi, Yuichi Tambo, Yoshihito Kogure, H. Yoshioka, M. Tamiya, Kiichiro Ninomiya, Eiji Iwama\",\"doi\":\"10.1016/j.cllc.2024.02.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":504941,\"journal\":{\"name\":\"Clinical Lung Cancer\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lung Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.cllc.2024.02.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lung Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.cllc.2024.02.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of first-line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas